Table 2.

Primary and secondary outcomes between the zinc deficiency group and the control group.

Outcome	ZD group (n = 4,145)		Control group (n = 4,145)		HR (95% CI)	P value	E-value (95% LCL)
	Events (n)	Incidence rate per 100 person-years	Events (n)	Incidence rate per 100 person-years
Primary outcome
All-cause mortality	558	13.47	405	9.78	1.46 (1.29, 1.66)	<0.001	2.28 (1.90)
MACEs	658	15.89	481	11.61	1.46 (1.30, 1.64)	<0.001	2.28 (1.92)
MAKEs	652	15.74	460	11.11	1.51 (1.34, 1.70)	<0.001	2.39 (2.01)
Secondary outcomes
All-cause hospitalization	2,102	50.75	1,894	45.72	1.24 (1.16, 1.32)	<0.001	1.59 (1.45)

MACE, major adverse cardiovascular event; MAKE, major adverse kidney event; ZD, zinc deficiency.